Buprenorphin-Mepha 0.4 mg

Buprenorphin-Mepha 0.4 mg is a medicine authorised by Swissmedic under authorisation number 65188. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 12 December 2014 and the authorisation is valid without a time limit. ATC code N07BC01 places the medicine in the group Other nervous system drugs.

  • Dispensing category A+
  • Authorisation number 65188
  • ATC N07BC01
  • Synthetic medicines
Authorisation data
Authorisation number65188
NameBuprenorphin-Mepha 0.4 mg
Full nameBuprenorphin-Mepha 0.4 mg, Sublingualtabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryA+ · Prescription with conditions
ATC codeN07BC01
First authorisation12 December 2014
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Buprenorphin-Mepha 0.4 mg, SublingualtablettenA+12 December 2014
2Buprenorphin-Mepha 2 mg, SublingualtablettenA+12 December 2014
3Buprenorphin-Mepha 8 mg, SublingualtablettenA+12 December 2014

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
17Tablette(n)N07BC0101.01.3.A+
228Tablette(n)N07BC0101.01.3.A+
37Tablette(n)N07BC0101.01.3.A+
428Tablette(n)N07BC0101.01.3.A+
57Tablette(n)N07BC0101.01.3.A+
628Tablette(n)N07BC0101.01.3.A+

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Buprenorphin-Mepha 0.4 mg authorised in Switzerland?

Yes. Buprenorphin-Mepha 0.4 mg is authorised by Swissmedic under authorisation number 65188, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Buprenorphin-Mepha 0.4 mg have?

Buprenorphin-Mepha 0.4 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.

Who is the authorisation holder of Buprenorphin-Mepha 0.4 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com